Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

13

Full text

10

Free full text

5

Publication Types

Journal Article

13

Systematic Review

3

Review

3

Research Support, Non-U.S. Gov't

3

Clinical Trial

3

Meta-Analysis

2

Observational Study

2

Randomized Controlled Trial

2

Multicenter Study

2

Clinical Trial Protocol

1

Controlled Clinical Trial

1

Publication Year

From

To

Quick links

Individual year

2026

1

2023

2

2018

1

2017

1

2016

1

2005

1

2004

1

2003

1

2002

1

2001

2

2000

1

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Doxapram""[mesh_terms]

13 Results

Searching titles within these results

Doxapram for the prevention and treatment of apnea in preterm infants.

Shannon Evans, Ema Avdic, Sara Pessano, Michelle Fiander, Roger Soll, Matteo Bruschettini

The Cochrane database of systematic reviews 2023;10(10):CD014145

Treatment of apnea of prematurity.

Varsha Bhatt-Mehta, Robert E Schumacher

Paediatric drugs 2003;5(3):195-210

Risks and benefits of therapies for apnoea in premature infants.

J M Hascoet, I Hamon, M J Boutroy

Drug safety 2001;23(5):363-79

Current options in the management of apnea of prematurity.

J Bhatia

Clinical pediatrics 2000;39(6):327-36

Doxapram Treatment for Apnea of Prematurity: A Systematic Review.

Roseanne J S Vliegenthart, Christine H Ten Hove, Wes Onland, Anton H L C van Kaam

Neonatology 2017;111(2):162-171

Dosing practices of caffeine therapy for apnoea of prematurity: a retrospective single-centre observational study.

Odunayo Adebukola Temitope Fatunla, Coen S Zandvoort, Shellie Robinson, Eleri Adams, Caroline Hartley

BMJ paediatrics open 2026;10(1):

QT interval lengthening in premature infants treated with doxapram.

C Maillard, M J Boutroy, J Fresson, F Barbé, J M Hascoët

Clinical pharmacology and therapeutics 2002;70(6):540-5

Doxapram versus methylxanthine for apnea in preterm infants.

D J Henderson-Smart, P Steer

The Cochrane database of systematic reviews 2001

Doxapram Dosing for Apnea of Prematurity Based on Postmenstrual Age and Gender: A Randomized Controlled Trial.

E Greze, M Benard, I Hamon, C Casper, F E Haddad, M-J Boutroy, J-M Hascoët

Paediatric drugs 2016;18(6):443-449

Doxapram versus placebo in preterm newborns: a study protocol for an international double blinded multicentre randomized controlled trial (DOXA-trial).

Jarinda A Poppe, Robert B Flint, Anne Smits, Sten P Willemsen, Kelly K Storm, Debbie H Nuytemans, Wes Onland, Marten J Poley, Willem P de Boode, Katherine Carkeek, Vincent Cassart, Luc Cornette, Peter H Dijk, Marieke A C Hemels, Isabelle Hermans, Matthias C Hütten, Dorottya Kelen, Ellen H M de Kort, André A Kroon, Julie Lefevere, Katleen Plaskie, Breanne Stewart, Michiel Voeten, Mirjam M van Weissenbruch, Olivia Williams, Inge A Zonnenberg, Thierry Lacaze-Masmonteil, Arjan B Te Pas, Irwin K M Reiss, Anton H van Kaam, Karel Allegaert, G Jeroen Hutten, Sinno H P Simons

Trials 2023;24(1):656

Periextubation caffeine in preterm neonates: a randomized dose response trial.

P A Steer, V J Flenady, A Shearman, T C Lee, D I Tudehope, B G Charles

Journal of paediatrics and child health 2004;39(7):511-5

Simultaneous quantification of fentanyl, sufentanil, cefazolin, doxapram and keto-doxapram in plasma using liquid chromatography-tandem mass spectrometry.

Birgit C P Koch, Robert B Flint, Soma Bahmany, Bart C H van der Nagel

Biomedical chromatography : BMC 2018;32(10):e4290

Olfactory stimulation prevents apnea in premature newborns.

Jean Messer, Christophe Gaugler, Luc Marlier

Pediatrics 2005;115(1):83-8

Results: 1 – 13 / 13

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.